These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29121914)

  • 1. Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing.
    Krishnaswamy S; Mohammed AK; Tripathi G; Alokail MS; Al-Daghri NM
    BMC Cancer; 2017 Nov; 17(1):738. PubMed ID: 29121914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the splice variants of Recepteur d'Origine nantais (RON) in lung cancer cell lines.
    Krishnaswamy S; Bukhari I; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
    Gene; 2018 Dec; 679():335-340. PubMed ID: 30223007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel splicing variants of recepteur d'origine nantais (RON) tyrosine kinase involving exons 15-19 in lung cancer.
    Krishnaswamy S; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
    Lung Cancer; 2016 Feb; 92():41-6. PubMed ID: 26775595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recepteur d'Origine nantais (RON) tyrosine kinase splicing variants lacking exons 18 and 19 occur ubiquitously in lung cancer.
    Krishnaswamy S; Mohammed AK; Amer OE; Tripathi G; Alokail MS; Al-Daghri NM
    Int J Clin Exp Med; 2015; 8(11):20778-86. PubMed ID: 26885001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant.
    Eckerich C; Schulte A; Martens T; Zapf S; Westphal M; Lamszus K
    J Neurochem; 2009 May; 109(4):969-80. PubMed ID: 19519771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel RON splice variant lacking exon 2 activates the PI3K/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells.
    Ling Y; Kuang Y; Chen LL; Lao WF; Zhu YR; Wang LQ; Wang D
    Oncotarget; 2017 Jun; 8(24):39101-39116. PubMed ID: 28388571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative genomic analyses of recepteur d'origine nantais and its prognostic value in cancer.
    Yu H; Yuan J; Xiao C; Qin Y
    Int J Mol Med; 2013 May; 31(5):1248-54. PubMed ID: 23483216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel splicing variants from RON proto-oncogene pre-mRNA.
    Moon H; Cho S; Yang X; Zhou J; Loh TJ; Zheng X; Shen H
    Oncol Rep; 2012 Dec; 28(6):2217-20. PubMed ID: 22993024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of RON in small and non-small cell lung cancers.
    Kanteti R; Krishnaswamy S; Catenacci D; Tan YH; EL-Hashani E; Cervantes G; Husain AN; Tretiakova M; Vokes EE; Huet H; Salgia R
    Genes Chromosomes Cancer; 2012 Sep; 51(9):841-51. PubMed ID: 22585712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.
    Chakedis J; French R; Babicky M; Jaquish D; Howard H; Mose E; Lam R; Holman P; Miyamoto J; Walterscheid Z; Lowy AM
    Oncogene; 2016 Jun; 35(25):3249-59. PubMed ID: 26477314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples.
    Angeloni D; Danilkovitch-Miagkova A; Ivanov SV; Breathnach R; Johnson BE; Leonard EJ; Lerman MI
    Genes Chromosomes Cancer; 2000 Oct; 29(2):147-56. PubMed ID: 10959094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets.
    Lu Y; Yao HP; Wang MH
    Cancer Lett; 2007 Nov; 257(2):157-64. PubMed ID: 17889431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
    Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
    Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
    Wang MH; Yao HP; Zhou YQ
    Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RON alternative splicing regulation in primary ovarian cancer.
    Mayer S; Hirschfeld M; Jaeger M; Pies S; Iborra S; Erbes T; Stickeler E
    Oncol Rep; 2015 Jul; 34(1):423-30. PubMed ID: 25997828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
    Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
    Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer.
    Wu Z; Zhang Z; Ge X; Lin Y; Dai C; Chang J; Liu X; Geng R; Wang C; Chen H; Sun M; Guo W; Li J
    Oncotarget; 2015 Dec; 6(38):40519-34. PubMed ID: 26528757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the Sema-PSI extracellular domain of human RON receptor tyrosine kinase.
    Chao KL; Tsai IW; Chen C; Herzberg O
    PLoS One; 2012; 7(7):e41912. PubMed ID: 22848655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.
    Kim J; Koh DI; Lee M; Park YS; Hong SW; Shin JS; Lee MS; Kim MH; Lee JH; Jeong J; Bae S; Hong JK; Jeong HR; Ryu YS; Kim SM; Choi M; Kim H; Ryu H; Hur SC; Park J; Hur DY; Jin DH
    Cell Death Differ; 2023 Dec; 30(12):2491-2507. PubMed ID: 37926711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNA targeting of Recepteur d'Origine Nantais induces apoptosis via modulation of nuclear factor-kappaB and Bcl-2 family in gastric cancer cells.
    Park JS; Park JH; Lee S; Joo YE; Jung YD
    Oncol Rep; 2010 Sep; 24(3):709-14. PubMed ID: 20664977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.